Details of the Drug

General Information of Drug (ID: DMOWQAF)

Drug Name
Recombinant human iduronate-2-sulfatase
Synonyms GC-1111; Recombinant human iduronate-2-sulfatase (Hunter syndrome); Recombinant human iduronate-2-sulfatase (Hunter syndrome), Green Cross
Indication
Disease Entry ICD 11 Status REF
Hunter syndrome 5C56.31 Phase 3 [1]
Cross-matching ID
TTD ID
D0L1DR

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Iduronate 2-sulfatase (IDS) TTNY2AP IDS_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01645189) Safety and Efficacy of Hunterase. U.S. National Institutes of Health.
2 The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II. PLoS One. 2014 Jan 13;9(1):e85074.